Interestingly and surprisingly, caerin 1.1/1.9 enhanced the anti-tumour responses of ICB and therapeutic vaccination therapy [23], also through activating the IFN-Stat1 signalling pathway of macrophages in TC-1 model (Figure 3 and Figure S3), and in the B16 tumour model. Here, IFNA1 is linked to neoplasm.